Exploiting the Zinc Finger Degrome Targeted By Lenalidomide to Engineer Reversible Off-Switch Degradable Chimeric Antigen Receptors
Max Jan(Broad Institute), Benjamin L. Ebert(Broad Institute), Andrew A. Guirguis(Broad Institute), Marcela V. Maus(Broad Institute), Mikołaj Słabicki(Broad Institute), Alexander Tepper(Broad Institute), Ana P. Castaño(Harvard University), Amanda Walker(Broad Institute), Amanda A. Bouffard(Harvard University), Daniel E. Grinshpun(Broad Institute), Taeyoon Kyung(Allen Institute), Michael E. Birnbaum(Ragon Institute of MGH, MIT and Harvard), Jessica A. Gasser(Broad Institute), Quinlan Sievers(Broad Institute)
Cited by 0
Related Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
|Proceedings of the National Academy of Sciences|2005|56.5k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k